What Is Postherpetic Neuralgia?

Postherpetic neuralgia (PHN) is a complication of shingles where nerve pain persists long after the shingles rash has healed. It's the most common complication of shingles, affecting 10-18% of people who get shingles. The pain occurs in the area where the shingles rash appeared and can last months or even years.1

How It Develops2

  • Shingles damages nerve fibers
  • Damaged nerves send abnormal signals
  • Pain continues after rash heals
  • PHN defined as pain lasting 90+ days after rash

Symptoms

  • Burning, sharp, or stabbing pain
  • Extreme sensitivity to touch
  • Itching or numbness
  • Pain from light touch (allodynia)
  • Usually on one side of body
  • Commonly affects chest, face

Risk Factors for Developing PHN

  • Age over 50 (risk increases with age)
  • Severe shingles rash
  • Severe pain during shingles
  • Delayed antiviral treatment
  • Shingles on face or torso
  • Weakened immune system

Prevention3

  • Shingles vaccine (Shingrix) most effective
  • Recommended for adults 50+
  • Early antiviral treatment for shingles
  • Prompt treatment reduces PHN risk

Treatment Options

Medications

  • Anticonvulsants (gabapentin, pregabalin)
  • Tricyclic antidepressants
  • Lidocaine patches (topical)
  • Capsaicin cream
  • Opioids (for severe cases)

Other Treatments

  • Nerve blocks
  • TENS therapy
  • Spinal cord stimulation (severe cases)
  • Psychological support

Living with PHN

  • Protect sensitive skin from touch
  • Wear soft, loose clothing
  • Keep skin clean and dry
  • Manage stress (can worsen pain)
  • Join support groups

Prognosis

  • Pain often improves over time
  • Some have pain for years
  • Treatment can significantly reduce pain
  • Combination approaches often work best

References

  1. Johnson RW, Rice AS. Postherpetic neuralgia. N Engl J Med. 2014;371(16):1526-1533.
  2. Hadley GR, Gayle JA, Ripoll J, et al. Post-herpetic neuralgia: a review. Curr Pain Headache Rep. 2016;20(3):17.
  3. Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087-2096.